Bond Biosciences, Inc. announced it raised $200,000 in an initial filing from an offering of $200,000

Sep 14, 2020•about 5 years ago

Amount Raised

$200,000

ParkvilleBiotechnologyHealthcare

Company Information

Company

Bond Biosciences

Location

170 English Landing Drive

Parkville, Missouri, United States

About

Bond Biosciences, Inc. is a privately held, clinical stage biopharmaceutical company focused on the discovery and development of first-in-class non-absorbed oral therapeutics that bind excess ions locally in the gastrointestinal (GI) tract to treat or prevent human disease.

Related People

0 contacts

No contacts found in Executives department

Try selecting a different department above

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Bond Biosciences, Inc. announced it raised $200,000 in an initial filing from an offering of $200,000

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information